Welcome to the Clot Club Blog. The first rule of CLOT CLUB is:  We DO talk about CLOT CLUB. If you have any questions about any of the topics discussed herein, please contact us


Clot Club #47

A REVIEW OF THE XXXVTH INTERNATIONAL SYMPOSIUM ON TECHNICAL INNOVATIONS IN LABORATORY HEMATOLOGY 2023 (ISLH 2023)

David L. McGlasson, MS, MLS(ASCP)

Posted: September 7, 2023


Clot Club #46

ISTH 2023 BLOG COMPILATION

Posted: August 7, 2023


Clot Club #45

EARLY INSIGHTS FROM RSA 2023

Abi Kasberg, PhD

Posted: August 1, 2023


Clot Club #44

THROMBOSIS AND HEMOSTASIS IN LIVER DISEASE AND KIDNEY DISEASE: A CALL FOR MORE RESEARCH

Abi Kasberg, PhD

Posted: July 26, 2023


Clot Club #43

ATS THOUGHTS FROM A SECOND-TIMER– OLIVIA STRICKER, PhD

Olivia Stricker, PhD

Posted: July 13, 2023


Clot Club #42

SOT 2023, RECAP THROUGH A DIAPHARMA LENS

Olivia Stricker, PhD

Posted: April 19, 2023


Clot Club #41

ANTICIPATED NASH DRUG APPROVAL WILL REQUIRE EXPANDED NON-INVASIVE TESTING: NASH-TAG 2023 TAKEAWAYS

Abi Kasberg, PhD

Posted: April 19, 2023


Clot Club #40

SHOULD DIRECT ORAL ANTICOAGULANTS (DOAC) BE USED IN INDIVIDUALS WITH ANTIPHOSPHOLIPID SYNDROME (APS) VS LONG TERM WARFARIN TREATMENT?

David L. McGlasson, MS, MLS(ASCP)

Posted: April 14, 2023


Clot Club #39

WHY ISN’T THIS BEING FUNDED?! THOUGHTS FROM HTRS 2023, AND A GRANT OPPORTUNITY FROM DIAPHARMA

Jennifer J. Kiblinger, Scientific Director

Posted: April 13, 2023


Clot Club #38

CHOOSING WISELY – COAGULATION TESTING RECOMMENDATIONS

David L. McGlasson, MS, MLS(ASCP)

Posted: January 23, 2023


Clot Club #37

A STEEEEP LEARNING CURVE: MY TAKE HOME MESSAGES FROM AN ALCOHOL-ASSOCIATED LIVER DISEASE MEETING FROM A NEWBIE

Olivia Stricker, PhD

Posted: January 3, 2023


Clot Club #36

THE DEBATE OF EARLY-LIVER TRANSPLANTATION FOR ALCOHOL-ASSOCIATED LIVER DISEASES

Abi Kasberg, PhD

Posted: December 21, 2022


Clot Club #35

THSNA 2022 RECAP

David L. McGlasson, MS, MLS(ASCP)

Posted: October 7, 2022


Clot Club #34

VACCINE-INDUCED THROMBOTIC THROMBOCYTOPENIA (VITT): INSIGHTS FROM ISTH 2022

Abi Kasberg, PhD

Posted: September 23, 2022


Clot Club #33

EMERGING THERAPEUTIC TARGETS FOR HEREDITARY ANGIOEDEMA 

Abi Kasberg, PhD

Posted: August 31, 2022


Clot Club #32

CHROMOGENIC FACTOR X ASSAYS vs the PT/INR TO MONITOR SUBJECTS ON COUMADIN THERAPY WHEN AN INDIVIDUAL APPROACH IS NECESSARY

Posted: June 28, 2022


Clot Club #31

IMMUNE-MEDIATED LIVER INJURY CAUSED BY CHECKPOINT INHIBITORS (ILICI)

Abi Kasberg, PhD

Posted: May 4, 2022


Clot Club #30

COMPREHENSIVE PRIMARY HEMOSTASIS ASSESSMENTS TO DIAGNOSE AND MONITOR VWD

Abi Kasberg, PhD

Posted: April 11, 2022


Clot Club #29

POTENTIAL FUTURE USES FOR RECOMBINANT ADAMTS13

David L. McGlasson, MS, MLS(ASCP)

Posted: March 25, 2022


Clot Club #28

THE NEW NOVEL ANTICOAGULANTS XI(a) and XII(a). THE CONTACT FACTOR INHIBITORS: Battling thromboembolism.

David L. McGlasson, MS, MLS(ASCP)

Posted: December 17, 2021


Clot Club #27

A TRIO OF BIOMARKERS: A NOVEL MULTIVARIATE MODEL TO DETECT DILI & LIVER DAMAGE

Abi Kasberg, PhD

Posted: September 27, 2021


Clot Club #26

ISTH 2021

David L. McGlasson, MS, MLS(ASCP)

Posted: September 27, 2021


Clot Club #25

THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) CLINICAL TRIALS: TARGETING THE NEEDS LEFT BY CURRENT TREATMENT OPTIONS

Abi Kasberg, PhD

Posted: August 19, 2021


Clot Club #24

IN VITRO LIVER CULTURE SYSTEMS TO INVESTIGATE DILI

Abi Kasberg, PhD

Posted: July 8, 2021


Clot Club #23

HYPERCOAGULATION DURING SICKLE CELL DISEASE

Abi Kasberg, PhD

Posted: May 19, 2021


Clot Club #22

LUPUS ANTICOAGULANTS/ANTIPHOSPHOLIPID ANTIBODIES/ANTIPHOSPHOLIPID ANTIBODY SYNDROME – PART 2

David L. McGlasson, MS, MLS(ASCP)

Posted: April 29, 2021


Clot Club #21

LUPUS ANTICOAGULANTS/ANTIPHOSPHOLIPID ANTIBODIES/ANTIPHOSPHOLIPID ANTIBODY SYNDROME – PART 1

David L. McGlasson, MS, MLS(ASCP)

Posted: March 29, 2021


Clot Club #20

DETECTING HEMOGLOBIN VARIANTS DURING SICKLE CELL DISEASE RESEARCH: WHICH METHOD IS BEST?

Abi Kasberg, PhD

Posted: March 15, 2021


Clot Club #19

INSIGHTS INTO AN IMBALANCED vWF ANTIGEN TO ADAMTS-13 ACTIVITY RATIO IN COVID-19

Abi Kasberg, PhD

Posted: February 16, 2021


Clot Club #18

THSNA 2020 Virtual Meeting

David L. McGlasson, MS, MLS(ASCP)

Posted: December 8, 2020


Clot Club #17

PROPOSED MECHANISMS OF PLATELET DYNAMICS DURING COVID-19 

Abi Kasberg, PhD

Posted: October 2, 2020


Clot Club #16

ACTIVATED PROTEIN C RESISTANCE (APCR), FACTOR V LEIDEN (FVL), AND A CASE REPORT OF A FAMILY WITH THE PRESENCE OF FVL OVER 5 GENERATIONS.

David L. McGlasson, MS, MLS(ASCP)

Posted: September 25, 2020


Clot Club #15

COVID-19 FREQUENTLY ASKED QUESTIONS

Abi Kasberg, PhD

Posted: September 3, 2020


Clot Club #14

COVID-19 AND CLOTTING (Part II)

David L. McGlasson, MS MLS(ASCP)

Posted: August 3, 2020


Clot Club #13

ISTH 2020

David L. McGlasson, MS MLS(ASCP)

Posted: August 3, 2020


Clot Club #12

COVID-19 AND CLOTTING

David L. McGlasson, MS MLS(ASCP)

Posted: May 26, 2020


Clot Club #11

HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) – A SENSIBLE LABORATORY APPROACH (HOPEFULLY)

David L. McGlasson, MS MLS(ASCP)

Posted: April 2, 2020


Clot Club #10

THE LATEST RESEARCH ON DIRECT ORAL ANTICOAGULANT (DOAC) INTERFERENCES IN TESTING

David L. McGlasson, MS MLS(ASCP)

Posted: January 28, 2020


Clot Club #9

THE CHROMOGENIC FACTOR X ASSAY (CFX)

David L. McGlasson, MS MLS(ASCP)

Posted: December 10, 2019


Clot Club #8

CANNABINOID EFFECTS ON COAGULATION? DOES ORGANIC WEED MESS WITH YOUR BLOOD FLOW?

David L. McGlasson, MS MLS(ASCP)

Posted: September 26, 2019


Clot Club #7

LABORATORY TESTS FOR VON WILLEBRAND FACTOR (VWF)

David L. McGlasson, MS MLS(ASCP)

Posted: August 20, 2019


Clot Club #6

HTRS 2019 CONFERENCE SUMMARY

David L. McGlasson, MS MLS(ASCP)

Posted: June 25, 2019


Clot Club #5

FACTOR XIII

Diapharma Group, Inc.

Posted: April 30, 2019


Clot Club #4

HEPARIN IN THE NEWS – THE GENENE JONES “KILLER NURSE” STORY

David L. McGlasson, MS MLS(ASCP)

Posted: April 30, 2019


Clot Club #3

HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?

David L. McGlasson, MS MLS(ASCP)

Posted: March 22, 2019


Clot Club #2

UPDATE ON THE DIRECT ORAL ANTICOAGULANTS (DOACs): WHERE ARE WE IN THE LABORATORY ALMOST TEN YEARS LATER?

David L. McGlasson, MS MLS(ASCP)

Posted: February 7, 2019


Clot Club #1

“HERE THE CLOT THICKENS” – HEMOPHILIA A & B

David L. McGlasson, MS MLS(ASCP)

Posted: January 31, 2019


About David L. McGlasson, MS MLS(ASCP)


clot club